JP2021080416A - Dye for staining lipid bilayer and method for staining lipid bilayer using the same - Google Patents
Dye for staining lipid bilayer and method for staining lipid bilayer using the same Download PDFInfo
- Publication number
- JP2021080416A JP2021080416A JP2019211329A JP2019211329A JP2021080416A JP 2021080416 A JP2021080416 A JP 2021080416A JP 2019211329 A JP2019211329 A JP 2019211329A JP 2019211329 A JP2019211329 A JP 2019211329A JP 2021080416 A JP2021080416 A JP 2021080416A
- Authority
- JP
- Japan
- Prior art keywords
- lipid bilayer
- dyeing
- dye
- membrane
- bilayer membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000232 Lipid Bilayer Substances 0.000 title claims abstract description 113
- 238000010186 staining Methods 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title claims description 23
- 238000004043 dyeing Methods 0.000 claims description 79
- 239000012528 membrane Substances 0.000 claims description 74
- 239000000203 mixture Substances 0.000 claims description 47
- 210000001808 exosome Anatomy 0.000 claims description 39
- 125000004432 carbon atom Chemical group C* 0.000 claims description 16
- 210000000170 cell membrane Anatomy 0.000 claims description 16
- 239000012488 sample solution Substances 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 8
- 229910052760 oxygen Inorganic materials 0.000 claims description 8
- 239000001301 oxygen Substances 0.000 claims description 8
- -1 polyoxyethylene group Polymers 0.000 claims description 7
- 125000004429 atom Chemical group 0.000 claims description 5
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical group [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 4
- 125000002947 alkylene group Chemical group 0.000 claims description 4
- 239000004202 carbamide Substances 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 150000002632 lipids Chemical class 0.000 claims description 4
- 229910052711 selenium Inorganic materials 0.000 claims description 4
- 239000011669 selenium Chemical group 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 239000011593 sulfur Chemical group 0.000 claims description 4
- 239000002120 nanofilm Substances 0.000 claims 3
- 239000002245 particle Substances 0.000 abstract description 21
- 238000005259 measurement Methods 0.000 abstract description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 66
- 239000000975 dye Substances 0.000 description 64
- 239000000543 intermediate Substances 0.000 description 54
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 30
- 230000015572 biosynthetic process Effects 0.000 description 23
- 235000002597 Solanum melongena Nutrition 0.000 description 22
- 239000000243 solution Substances 0.000 description 20
- 238000003786 synthesis reaction Methods 0.000 description 18
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 15
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 14
- 239000012043 crude product Substances 0.000 description 14
- 239000012091 fetal bovine serum Substances 0.000 description 14
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 239000012074 organic phase Substances 0.000 description 12
- 239000000741 silica gel Substances 0.000 description 12
- 229910002027 silica gel Inorganic materials 0.000 description 12
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 238000010992 reflux Methods 0.000 description 10
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 8
- 239000001110 calcium chloride Substances 0.000 description 8
- 229910001628 calcium chloride Inorganic materials 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 239000002105 nanoparticle Substances 0.000 description 4
- PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 description 4
- 0 CCCCOCCC1*(CCOC=C*NC(C(CCC(O)O)NC(*)[C@@](C)(C*(C)=C)*C)=O)C1 Chemical compound CCCCOCCC1*(CCOC=C*NC(C(CCC(O)O)NC(*)[C@@](C)(C*(C)=C)*C)=O)C1 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000007821 HATU Substances 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002073 fluorescence micrograph Methods 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000004007 reversed phase HPLC Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 3
- HZTPKMIMXLTOSK-UHFFFAOYSA-N 2-bromohexanoic acid Chemical compound CCCCC(Br)C(O)=O HZTPKMIMXLTOSK-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- ARBOVOVUTSQWSS-UHFFFAOYSA-N hexadecanoyl chloride Chemical compound CCCCCCCCCCCCCCCC(Cl)=O ARBOVOVUTSQWSS-UHFFFAOYSA-N 0.000 description 2
- 230000008611 intercellular interaction Effects 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 210000001995 reticulocyte Anatomy 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000012192 staining solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 238000005199 ultracentrifugation Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- DQSHFKPKFISSNM-UHFFFAOYSA-N 2-methylbenzoxazole Chemical compound C1=CC=C2OC(C)=NC2=C1 DQSHFKPKFISSNM-UHFFFAOYSA-N 0.000 description 1
- JCEZOHLWDIONSP-UHFFFAOYSA-N 3-[2-[2-(3-aminopropoxy)ethoxy]ethoxy]propan-1-amine Chemical compound NCCCOCCOCCOCCCN JCEZOHLWDIONSP-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- JJSQYFCIGVKLRV-UHFFFAOYSA-N CC(C)(C(C)(C)Br)C(O)=O Chemical compound CC(C)(C(C)(C)Br)C(O)=O JJSQYFCIGVKLRV-UHFFFAOYSA-N 0.000 description 1
- LVEFFEYKAHZZKY-UHFFFAOYSA-N CC(C)(C(C)=C)c1ccccc1N Chemical compound CC(C)(C(C)=C)c1ccccc1N LVEFFEYKAHZZKY-UHFFFAOYSA-N 0.000 description 1
- RWWHFYFALJROTK-LZYBPNLTSA-N CC(C)(C(C)=[IH])c(cccc1)c1/N=C/C(CS)O Chemical compound CC(C)(C(C)=[IH])c(cccc1)c1/N=C/C(CS)O RWWHFYFALJROTK-LZYBPNLTSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940006460 bromide ion Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000000298 carbocyanine Substances 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000013045 cell staining test Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- ZFTFAPZRGNKQPU-UHFFFAOYSA-N dicarbonic acid Chemical compound OC(=O)OC(O)=O ZFTFAPZRGNKQPU-UHFFFAOYSA-N 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Chemical compound [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- PBKBURVPAHHUIK-AVUWLFEKSA-N phenyl-[(e)-3-phenyliminoprop-1-enyl]azanium;chloride Chemical compound Cl.C=1C=CC=CC=1N\C=C\C=NC1=CC=CC=C1 PBKBURVPAHHUIK-AVUWLFEKSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000009962 secretion pathway Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000007332 vesicle formation Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/02—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
- C09B23/06—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups three >CH- groups, e.g. carbocyanines
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/10—The polymethine chain containing an even number of >CH- groups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
Abstract
Description
本発明は、新規な脂質二分子膜染色用色素及びそれを用いた脂質二分子膜の染色方法に関する。 The present invention relates to a novel dye for dyeing a lipid bilayer film and a method for dyeing a lipid bilayer film using the same.
1983年に、脂質二分子膜からなる直径100nm程度の小胞が網状赤血球から分泌されることが発見され、エキソソーム(Exosome)と名付けられた(非特許文献1参照)。エキソソームの発見と前後して、様々な細胞が大きさ等の異なる膜小胞を分泌していることが発見され、様々な名称で呼称されているが、小胞の国際的な研究学会である国際細胞外小胞協会(International Society for Extracellular Vesicles(ISEV))は、これら細胞から分泌される小胞の総称として、細胞外小胞(extracellular vesicle)の使用を推奨している。エキソソームを始めとする細胞外小胞は、細胞間を移動しながら種々の生理活性物質を輸送していることが明らかにされつつある。多細胞生物において、細胞間の相互作用は多彩な生命活動に関与しており、その破綻は各種疾患につながることから、細胞外小胞の関与する細胞間相互作用の解明は、多彩な生命活動の背後に存在する分子機構の理解及び各種疾患の病態の理解、新たな診断法及び治療法の開発等につながることが期待されている。 In 1983, it was discovered that vesicles having a lipid bilayer membrane and having a diameter of about 100 nm were secreted from reticulocytes, and were named exosomes (see Non-Patent Document 1). Around the time of the discovery of exosomes, it was discovered that various cells secrete membrane vesicles of different sizes, and they are called by various names, but it is an international research society for vesicles. The International Society for Extracellular Vesicles (ISEV) recommends the use of extracellular vesicles as a general term for vesicles secreted from these cells. It is becoming clear that extracellular vesicles such as exosomes transport various physiologically active substances while moving between cells. In multicellular organisms, cell-cell interactions are involved in various life activities, and their breakdown leads to various diseases. Therefore, elucidation of cell-cell interactions involving extracellular vesicles is a variety of life activities. It is expected to lead to an understanding of the molecular mechanism behind the disease, an understanding of the pathophysiology of various diseases, and the development of new diagnostic and therapeutic methods.
エキソソームを始めとする細胞外小胞の形成及び分泌経路の研究のためには、細胞外小胞の脂質二分子膜を染色するための色素が必要である。従来用いられているエキソソームの蛍光染色用の色素としては、例えば、下記の式で表されるものが知られている(特許文献1、2参照)。 For the study of the formation and secretion pathways of extracellular vesicles including exosomes, a dye for staining the lipid bilayer membrane of extracellular vesicles is required. As a conventionally used dye for fluorescent staining of exosomes, for example, those represented by the following formulas are known (see Patent Documents 1 and 2).
しかしながら、上記の式で表される蛍光色素は、エキソソーム等の膜の染色に使用した場合、粒子を形成してエキソソームを肥大化させ、その性質を変化させるおそれがあるという問題が指摘されていると共に、粒子が小胞の内部に移行しバックグラウンド発光を生じさせるため、感度が低下するという問題が指摘されている。 However, it has been pointed out that the fluorescent dye represented by the above formula may form particles to enlarge the exosome and change its properties when used for staining a film such as an exosome. At the same time, it has been pointed out that the sensitivity is lowered because the particles migrate to the inside of the vesicles and cause background emission.
本発明はかかる事情に鑑みてなされたもので、脂質二分子膜に対する滞留性が高く、細胞外小胞の染色に用いる場合にも、粒子サイズ等を変化させることなく高感度での蛍光測定を可能にする脂質二分子膜染色用色素及びそれを用いた脂質二分子膜の染色方法を提供することを目的とする。 The present invention has been made in view of such circumstances, and has high retention on lipid bilayer membranes, and even when used for staining extracellular vesicles, high-sensitivity fluorescence measurement can be performed without changing the particle size or the like. It is an object of the present invention to provide a dye for dyeing a lipid bilayer membrane and a method for dyeing a lipid bilayer membrane using the same.
前記目的に沿う本発明の第1の態様は、下記の一般式(I)で表される脂質二分子膜染色用色素を提供することにより上記課題を解決するものである。 The first aspect of the present invention in line with the above object is to solve the above problem by providing a dye for dyeing a lipid bilayer film represented by the following general formula (I).
上記一般式(I)において、
Xは、酸素、イオウ、セレン又は式−CR11 2−(R11は、水素原子又は炭素数1〜5のアルキル基である。)で表される原子又は原子団であり、
nは、1又は2の自然数であり、
R1は、炭素数1〜12のアルキレン基であり、
R2は、式(CH2CH2O)m(mは、1〜10の自然数である。)で表されるポリオキシエチレン基を含む原子団であり、
R3は、炭素数6〜20のアルキル基であり、
L1、L2及びL3は、それぞれ独立して、エステル結合(−CO−O−)、アミド結合(−CO−NH−)、ウレタン結合(−NH−CO−O−)及び尿素結合(−NH−CO−NH−)からなる群より選択される結合基であり、
qは1〜5の自然数である。
In the above general formula (I)
X is oxygen, sulfur, selenium or formula -CR 11 2 - (. R 11 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms) is an atom or an atomic group represented by,
n is a natural number of 1 or 2
R 1 is an alkylene group having 1 to 12 carbon atoms.
R 2 is an atomic group containing a polyoxyethylene group represented by the formula (CH 2 CH 2 O) m (m is a natural number of 1 to 10).
R 3 is an alkyl group having 6 to 20 carbon atoms.
L 1 , L 2 and L 3 independently have an ester bond (-CO-O-), an amide bond (-CO-NH-), a urethane bond (-NH-CO-O-) and a urea bond (-NH-CO-O-). -NH-CO-NH-) is a binding group selected from the group consisting of
q is a natural number from 1 to 5.
本発明の第2の態様は、脂質二分子膜を含む試料溶液を準備する工程と、上記の一般式(I)で表される脂質二分子膜染色用色素及び/又はそれを含む染色用組成物を準備する工程と、前記脂質二分子膜染色用色素又は前記染色用組成物を前記試料溶液に添加し、前記脂質二分子膜を染色する工程を含む脂質二分子膜の染色方法を提供することにより上記課題を解決するものである。 A second aspect of the present invention includes a step of preparing a sample solution containing a lipid bilayer membrane, a dye for lipid bilayer dyeing represented by the above general formula (I), and / or a dyeing composition containing the same. Provided is a method for dyeing a lipid bilayer membrane, which comprises a step of preparing a product and a step of adding the dye for dyeing the lipid bilayer membrane or the dyeing composition to the sample solution and dyeing the lipid bilayer membrane. This solves the above problem.
本発明の第1の態様に係る脂質二分子膜染色用色素及び本発明の第2の態様に係る脂質二分子膜の染色方法において、前記脂質二分子膜が、細胞膜又は細胞膜に由来する脂質二分子膜であってもよい。 In the dye for dyeing a lipid bilayer membrane according to the first aspect of the present invention and the method for dyeing a lipid bilayer membrane according to the second aspect of the present invention, the lipid bilayer membrane is a cell membrane or a lipid bilayer derived from the cell membrane. It may be a molecular membrane.
本発明の第1の態様に係る脂質二分子膜染色用色素及び本発明の第2の態様に係る脂質二分子膜の染色方法において、前記脂質二分子膜がエキソソーム膜であってもよい。 In the dye for dyeing a lipid bilayer membrane according to the first aspect of the present invention and the method for dyeing a lipid bilayer membrane according to the second aspect of the present invention, the lipid bilayer membrane may be an exosome membrane.
本発明の第1の態様に係る脂質二分子膜染色用色素及び本発明の第2の態様に係る脂質二分子膜の染色方法において、上記一般式(I)中のXが、酸素又は式−C(CH3)2−で表される原子団であってもよい。 In the dye for dyeing a lipid bilayer film according to the first aspect of the present invention and the method for dyeing a lipid bilayer film according to the second aspect of the present invention, X in the above general formula (I) is oxygen or the formula-. It may be an atomic group represented by C (CH 3 ) 2-.
本発明の第1の態様に係る脂質二分子膜染色用色素及び本発明の第2の態様に係る脂質二分子膜の染色方法において、上記一般式(I)中のL1、L2及びL3がアミド結合であってもよい。 In the dye for dyeing a lipid bilayer film according to the first aspect of the present invention and the method for dyeing a lipid bilayer film according to the second aspect of the present invention, L 1 , L 2 and L in the above general formula (I). 3 may be an amide bond.
本発明の第1の態様に係る脂質二分子膜染色用色素及び本発明の第2の態様に係る脂質二分子膜の染色方法において、前記脂質二分子膜染色用色素が、下記の式9、15及び20のいずれか1つで表されるものであってもよい。
In the lipid bilayer dyeing dye according to the first aspect of the present invention and the lipid bilayer dyeing method according to the second aspect of the present invention, the lipid bilayer dyeing dye is the following
本発明によると、脂質二分子膜に対する滞留性が高く、細胞膜、エキソソーム等の細胞外小胞等の染色に好適に用いることができる脂質二分子膜染色用色素及び脂質二分子膜の染色方法が提供される。更に、本発明により提供される脂質二分子膜染色用色素は、染色条件下で粒子又は凝集体を形成しにくいため、エキソソーム等のサイズの小さな細胞外小胞の染色に用いる場合にも、粒子サイズを変化させたり、アーティファクトを生じさせたりすることなく高精度かつ高感度な蛍光測定を可能にする。 According to the present invention, a dye for dyeing a lipid bilayer membrane and a method for staining a lipid bilayer membrane, which have high retention on a lipid bilayer membrane and can be suitably used for staining extracellular vesicles such as cell membranes and exosomes, are available. Provided. Furthermore, since the dye for lipid bilayer staining provided by the present invention does not easily form particles or aggregates under staining conditions, the particles are also used for staining small extracellular vesicles such as exosomes. It enables highly accurate and highly sensitive fluorescence measurement without changing the size or causing artifacts.
続いて、本発明を具体化した実施の形態につき説明し、本発明の理解に供する。 Subsequently, an embodiment embodying the present invention will be described for understanding the present invention.
本発明の第1の実施の形態に係る脂質二分子膜染色用色素(以下、「脂質二分子膜染色用色素」と略称する場合がある)は、下記の一般式(I)で表される。 The lipid bilayer dyeing dye according to the first embodiment of the present invention (hereinafter, may be abbreviated as “lipid bilayer dyeing”) is represented by the following general formula (I). ..
上記一般式(I)において、Xは、酸素、イオウ、セレン又は式−CR11 2−(R11は、水素原子又は炭素数1〜5のアルキル基である。)で表される原子又は原子団であり、好ましくは酸素又は式−C(CH3)2−で表される原子団である。 In the general formula (I), X is oxygen, sulfur, selenium or formula -CR 11 2 - (. R 11 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms) represented by the atom or atoms It is a group, preferably oxygen or an atomic group represented by the formula −C (CH 3 ) 2−.
上記一般式(I)において、nは、1又は2の自然数である。 In the above general formula (I), n is a natural number of 1 or 2.
上記一般式(I)において、R1は、炭素数1〜12、好ましくは炭素数2〜8、より好ましくは炭素数4〜6のアルキレン基である。 In the above general formula (I), R 1 is an alkylene group having 1 to 12 carbon atoms, preferably 2 to 8 carbon atoms, and more preferably 4 to 6 carbon atoms.
上記一般式(I)において、R2は、式(CH2CH2O)m(mは、1〜10、好ましくは2〜8、より好ましくは3〜5の自然数である。)で表されるポリオキシエチレン基を含む原子団である。ポリオキシエチレン基の存在により、脂質二分子膜染色用色素に水溶性が付与され、染色溶液の調製に有機溶媒が不要になると共に、親水性環境下での凝集体や粒子の形成を抑制できる。 In the above general formula (I), R 2 is represented by the formula (CH 2 CH 2 O) m (m is a natural number of 1 to 10, preferably 2 to 8, and more preferably 3 to 5). It is an atomic group containing a polyoxyethylene group. The presence of the polyoxyethylene group imparts water solubility to the dye for lipid bilayer dyeing, eliminates the need for an organic solvent for preparing the dyeing solution, and suppresses the formation of aggregates and particles in a hydrophilic environment. ..
上記一般式(I)において、R3は、炭素数6〜20、好ましくは炭素数8〜18、より好ましくは炭素数10〜16のアルキル基、好ましくは直鎖アルキル基である。 In the above general formula (I), R 3 is an alkyl group having 6 to 20 carbon atoms, preferably 8 to 18 carbon atoms, more preferably an alkyl group having 10 to 16 carbon atoms, and preferably a linear alkyl group.
上記一般式(I)において、L1、L2及びL3は、それぞれ独立して、エステル結合(−CO−O−)、アミド結合(−CO−NH−)、ウレタン結合(−NH−CO−O−)及び尿素結合(−NH−CO−NH−)からなる群より選択される結合基であり、好ましくはアミド結合である。 In the above general formula (I), L 1 , L 2 and L 3 are independently ester-bonded (-CO-O-), amide bond (-CO-NH-), and urethane bond (-NH-CO). It is a binding group selected from the group consisting of −O−) and urea bond (−NH—CO—NH−), and is preferably an amide bond.
脂質二分子膜染色用色素は、側鎖にカルボン酸基を有することで、脂質二分子膜の透過性が抑制され、染色対象となる細胞や細胞外小胞の内部に脂質二分子膜染色用色素が移行することを抑制できる。上記一般式(I)において、qは1〜5、好ましくは1又は2の自然数である。 The dye for lipid bilayer staining has a carboxylic acid group in the side chain, so that the permeability of the lipid bilayer is suppressed, and the lipid bilayer is stained inside the cells and extracellular vesicles to be stained. It is possible to suppress the migration of the dye. In the above general formula (I), q is a natural number of 1 to 5, preferably 1 or 2.
上記の一般式(I)で表される脂質二分子膜染色用色素は、1価の正電荷を有しているため、対陰イオンと塩を形成している。対陰イオンは、蛍光発光を阻害せず、細胞毒性等を有しない限りにおいて、任意の陰イオンであってよい。対陰イオンの具体例としては、塩化物イオン、臭化物イオン、過塩素酸塩イオン、硝酸イオン、酢酸イオン、トリフルオロ酢酸イオン等が挙げられる。 Since the lipid bilayer dyeing dye represented by the above general formula (I) has a monovalent positive charge, it forms a salt with an anion. The anti-anion may be any anion as long as it does not inhibit fluorescence emission and has cytotoxicity or the like. Specific examples of the anion ion include chloride ion, bromide ion, perchlorate ion, nitrate ion, acetate ion, trifluoroacetate ion and the like.
脂質二分子膜染色用色素の好ましい具体例としては、下記の式9、15及び20で表されるものが挙げられる。
Preferred specific examples of the dye for dyeing a lipid bilayer film include those represented by the following
上記の式9、15及び20で表される脂質二分子膜染色用色素は、任意の公知の方法を用いて合成することができ、その合成経路の具体例としては、それぞれ、後述する実施例に示すものが挙げられる。
The dyes for lipid bilayer dyeing represented by the
本発明の第2の実施の形態に係る脂質二分子膜の染色方法(以下、「脂質二分子膜の染色方法」と略称される場合がある。)は、脂質二分子膜を含む試料溶液を準備する工程と、本発明の第1の実施の形態に係る脂質二分子膜染色用色素及び/又はそれを含む染色用組成物を準備する工程と、脂質二分子膜染色用色素又は染色用組成物を試料溶液に添加し、脂質二分子膜を染色する工程を有している。 The method for dyeing a lipid bilayer membrane according to the second embodiment of the present invention (hereinafter, may be abbreviated as "method for dyeing a lipid bilayer membrane") is a sample solution containing a lipid bilayer membrane. A step of preparing, a step of preparing a dye for lipid bilayer dyeing according to the first embodiment of the present invention and / or a dyeing composition containing the same, and a dye for dyeing a lipid bilayer or a composition for dyeing. It has a step of adding a substance to a sample solution and staining a lipid bilayer membrane.
染色対象となる脂質二分子膜は、リン脂質、糖脂質、ステロール等の両親媒性の脂質を含み、脂質二分子膜染色用色素で染色できる限りにおいて任意のものであってよく、脂質以外にタンパク質等を含んでいてもよい。染色対象となる脂質二分子膜の例としては、動物細胞の細胞膜、それに由来する脂質二分子膜を有するエキソソーム等の細胞外小胞等が挙げられる。 The lipid bilayer membrane to be stained contains phospholipids, glycolipids, sterols and other amphoteric lipids, and may be arbitrary as long as it can be stained with a dye for dyeing lipid bilayer membranes, in addition to lipids. It may contain proteins and the like. Examples of the lipid bilayer membrane to be stained include cell membranes of animal cells and extracellular vesicles such as exosomes having a lipid bilayer membrane derived from the cell membranes.
上記のもの等の染色対象を含む試料溶液は、染色対象を適当な溶液中に分散させることにより調製される。染色対象が細胞の場合、溶液は、緩衝剤、培地等を含むものであってもよい。エキソソーム等の細胞外小胞の場合、更に超遠心による単離等の処理を更に行ってもよい。 A sample solution containing a stain target such as the above is prepared by dispersing the stain target in an appropriate solution. When the staining target is cells, the solution may contain a buffer, a medium, or the like. In the case of extracellular vesicles such as exosomes, further treatment such as isolation by ultracentrifugation may be performed.
本発明の第1の実施の形態に係る脂質二分子膜染色用色素は水溶性を有しているため、直接試料溶液に添加することにより染色を行うこともできるが、例えば、脂質二分子膜染色用色素を適当な溶媒に溶解させることにより脂質二分子膜染色用色素を含む染色用組成物を調製してもよい。上記のとおり、本発明の第1の実施の形態に係る脂質二分子膜染色用色素は水溶性を有しているため、溶媒は有機溶媒を含んでいる必要はない。 Since the dye for dyeing a lipid bilayer membrane according to the first embodiment of the present invention has water solubility, it can be dyed by directly adding it to a sample solution. For example, a lipid bilayer membrane A dyeing composition containing a lipid bilayer dyeing dye may be prepared by dissolving the dyeing dye in an appropriate solvent. As described above, since the dye for dyeing the lipid bilayer film according to the first embodiment of the present invention is water-soluble, the solvent does not need to contain an organic solvent.
染色は、脂質二分子膜染色用色素又はそれを含む染色用組成物を試料溶液に添加することにより行われる。必要に応じて、所定時間インキュベートを行う等の処理を適宜行うこともできる。染色像の観察は、蛍光顕微鏡等の任意の公知の方法を用いて行うことができる。エキソソーム等の粒子数及び粒子サイズの解析には、ナノ粒子トラッキング解析(NTA)等の方法を用いることができる。 Staining is performed by adding a dye for dyeing a lipid bilayer membrane or a dyeing composition containing the same to a sample solution. If necessary, processing such as incubation for a predetermined time can be performed as appropriate. The stained image can be observed by using any known method such as a fluorescence microscope. A method such as nanoparticle tracking analysis (NTA) can be used for the analysis of the number of particles and the particle size of exosomes and the like.
次に、本発明の作用効果を確認するために行った実施例について説明する。なお、以下の記載において、「式nで表される中間体」、「式nで表される脂質二分子膜染色用色素」を、それぞれ、「中間体n」、「脂質二分子膜染色用色素n」と略称する場合がある。
実施例1:脂質二分子膜染色用色素の合成
中間体1の合成
Next, an example carried out for confirming the action and effect of the present invention will be described. In the following description, "intermediate represented by formula n" and "dye for lipid bilayer dyeing represented by formula n" are referred to as "intermediate n" and "lipid bilayer dyeing", respectively. It may be abbreviated as "dye n".
Example 1: Synthesis of dye for lipid bilayer membrane staining Synthesis of intermediate 1
ナスフラスコに、4,7,10−トリオキサ−1,13−トリデカンジアミンを加えた。クロロホルムを加えて溶解し、Boc2O/クロロホルム溶液を滴下した。室温で撹拌後、飽和重曹水溶液/クロロホルムで分液し、有機相を飽和食塩水で洗浄後、減圧濃縮した。粗生成物をシリカゲルカラム(クロロホルム/メタノール)で精製し、中間体1を得た。 4,7,10-trioxa-1,13-tridecanediamine was added to the eggplant flask. Chloroform was added and dissolved, and a Boc 2 O / chloroform solution was added dropwise. After stirring at room temperature, the solution was separated with saturated aqueous sodium hydrogen carbonate solution / chloroform, and the organic phase was washed with saturated brine and concentrated under reduced pressure. The crude product was purified by silica gel column (chloroform / methanol) to obtain Intermediate 1.
中間体2の合成 Synthesis of intermediate 2
ナスフラスコにパルミチン酸と塩化チオニルを加え、塩化カルシウム管を接続し撹拌した。DMFを一滴加え、40℃で1時間撹拌した。減圧濃縮後、無水トルエンを加え再度減圧濃縮し、塩化パルミトイルを得た。ナスフラスコにL−グルタミン酸−γ−t−ブチルエステル、THF、水、ジイソプロピルエチルアミンを加え、撹拌した。塩化パルミトイルをTHFに溶解し、ナスフラスコに添加した。クロロホルム/5%クエン酸水溶液で分液し、有機相を飽和食塩水で洗浄後、減圧濃縮した。粗生成物をシリカゲルカラム(クロロホルム/メタノール)で精製し、中間体2を得た。 Palmitic acid and thionyl chloride were added to the eggplant flask, a calcium chloride tube was connected, and the mixture was stirred. One drop of DMF was added and the mixture was stirred at 40 ° C. for 1 hour. After concentration under reduced pressure, anhydrous toluene was added and concentrated under reduced pressure again to obtain palmitoyl chloride. L-Glutamic acid-γ-t-butyl ester, THF, water and diisopropylethylamine were added to the eggplant flask and stirred. Palmitoyl chloride was dissolved in THF and added to an eggplant flask. The mixture was separated by an aqueous chloroform / 5% citric acid solution, the organic phase was washed with saturated brine, and concentrated under reduced pressure. The crude product was purified on a silica gel column (chloroform / methanol) to obtain Intermediate 2.
中間体3の合成 Synthesis of intermediate 3
ナスフラスコにクロロホルムと中間体2、ジイソプロピルエチルアミンを加え、塩化カルシウム管を接続し撹拌した。DSC(炭酸ジ(N−スクシンイミジル))/クロロホルム溶液を添加した。室温で撹拌後、クロロホルム/水で分液し、有機相を飽和食塩水で洗浄し、減圧濃縮した。粗生成物をシリカゲルカラム(ヘキサン/酢酸エチル)で精製し、中間体3を得た。 Chloroform, intermediate 2 and diisopropylethylamine were added to the eggplant flask, a calcium chloride tube was connected, and the mixture was stirred. DSC (dicarbonate (N-succinimidyl)) / chloroform solution was added. After stirring at room temperature, the mixture was separated with chloroform / water, the organic phase was washed with saturated brine, and concentrated under reduced pressure. The crude product was purified on a silica gel column (hexane / ethyl acetate) to give Intermediate 3.
中間体4の合成 Synthesis of intermediate 4
ナスフラスコに2,3,3−トリメチルインドレニンとアセトニトリルを加え、撹拌した。ブロモヘキサン酸を加え、還流管を接続し、終夜加熱還流した。室温に冷却し、4M HCl/THFとエーテルを加えろ取した。粗生成物をエーテルに懸濁し、再度ろ取することで中間体4を得た。 2,3,3-trimethylindrenin and acetonitrile were added to the eggplant flask and stirred. Bromohexaneic acid was added, a reflux tube was connected, and the mixture was heated under reflux overnight. The mixture was cooled to room temperature, 4M HCl / THF and ether were added and collected by filtration. The crude product was suspended in ether and collected by filtration again to give Intermediate 4.
中間体5の合成 Synthesis of intermediate 5
ナスフラスコに中間体4とピリジンを加え、還流管を接続し撹拌した。オルトギ酸トリメチルを加え、終夜加熱還流した。減圧濃縮し、クロロホルム/1M塩酸で分液し、有機相を飽和食塩水で洗浄し減圧濃縮した。粗生成物をシリカゲルカラム(クロロホルム/メタノール)で精製し、中間体5を得た。 Intermediate 4 and pyridine were added to the eggplant flask, a reflux tube was connected, and the mixture was stirred. Trimethyl orthoformate was added and the mixture was heated under reflux overnight. The mixture was concentrated under reduced pressure, separated with chloroform / 1M hydrochloric acid, and the organic phase was washed with saturated brine and concentrated under reduced pressure. The crude product was purified on a silica gel column (chloroform / methanol) to obtain Intermediate 5.
中間体6の合成 Synthesis of intermediate 6
ナスフラスコに中間体5と、DMF、HATUを加え、塩化カルシウム管を接続し撹拌した。中間体1、ジイソプロピルエチルアミンを含むDMF溶液を添加し、終夜撹拌した。減圧濃縮し、クロロホルム/5%クエン酸水溶液で分液し、有機相を飽和食塩水で洗浄し、減圧濃縮した。粗生成物をシリカゲルカラム(クロロホルム/メタノール)で精製した。 Intermediate 5, DMF, and HATU were added to the eggplant flask, a calcium chloride tube was connected, and the mixture was stirred. A DMF solution containing Intermediate 1 and diisopropylethylamine was added and stirred overnight. The mixture was concentrated under reduced pressure, separated by a chloroform / 5% aqueous citric acid solution, the organic phase was washed with saturated brine, and concentrated under reduced pressure. The crude product was purified on a silica gel column (chloroform / methanol).
中間体7、8の合成
Synthesis of
ナスフラスコに中間体6とクロロホルムを加え、溶解した。TFA(トリフルオロ酢酸)を加え、40℃で1時間撹拌した。減圧濃縮し中間体7を得た。ナスフラスコに中間体7とDMF,ジイソプロピルエチルアミンを加え、撹拌した。塩化カルシウム管を接続し、中間体3のDMF溶液を添加し、室温で終夜撹拌した。減圧濃縮後、クロロホルム/水で分液し、有機相を飽和食塩水で洗浄し、減圧濃縮した。シリカゲルカラム(クロロホルム/メタノール)で精製し、中間体8を得た。
Intermediate 6 and chloroform were added to the eggplant flask and dissolved. TFA (trifluoroacetic acid) was added, and the mixture was stirred at 40 ° C. for 1 hour. It was concentrated under reduced pressure to obtain
脂質二分子膜染色用色素9の合成
Synthesis of
ナスフラスコに中間体8とクロロホルムを加え、溶解した。TFA(トリフルオロ酢酸)を加え、40℃で1時間撹拌した。減圧濃縮した。粗生成物を逆相HPLC(0.1% TFAを含む水/アセトニトリル)で精製し、赤色発光する脂質二分子膜染色用色素9を得た。
Intermediate 8 and chloroform were added to the eggplant flask and dissolved. TFA (trifluoroacetic acid) was added, and the mixture was stirred at 40 ° C. for 1 hour. Concentrated under reduced pressure. The crude product was purified by reverse phase HPLC (water / acetonitrile containing 0.1% TFA) to obtain a
中間体10の合成 Synthesis of intermediate 10
ナスフラスコに2−メチルベンゾオキサゾールとブロモヘキサン酸を加え、還流管を接続し、終夜加熱還流した。室温に冷却し、ろ取した。粗生成物をエーテルに懸濁し、再度ろ取することで中間体10を得た。
2-Methylbenzoxazole and bromohexaneic acid were added to the eggplant flask, a reflux tube was connected, and the mixture was heated under reflux overnight. It was cooled to room temperature and collected by filtration. The crude product was suspended in ether and collected by filtration again to give
中間体11の合成 Synthesis of intermediate 11
ナスフラスコに中間体10とピリジンを加え、還流管を接続し撹拌した。オルトギ酸トリメチルを加え、終夜加熱還流した。減圧濃縮し、クロロホルム/1M塩酸で分液し、有機相を飽和食塩水で洗浄し減圧濃縮した。粗生成物をシリカゲルカラム(クロロホルム/メタノール)で精製し、中間体11を得た。
中間体12の合成 Synthesis of intermediate 12
ナスフラスコに中間体11とDMF、HATUを加え、塩化カルシウム管を接続し撹拌した。中間体1、ジイソプロピルエチルアミンを含むDMF溶液を添加し、終夜撹拌した。減圧濃縮し、クロロホルム/5%クエン酸水溶液で分液し、有機相を飽和食塩水で洗浄し、減圧濃縮した。粗生成物をシリカゲルカラム(クロロホルム/メタノール)で精製し、中間体12を得た。 Intermediate 11, DMF, and HATU were added to the eggplant flask, a calcium chloride tube was connected, and the mixture was stirred. A DMF solution containing Intermediate 1 and diisopropylethylamine was added and stirred overnight. The mixture was concentrated under reduced pressure, separated by a chloroform / 5% aqueous citric acid solution, the organic phase was washed with saturated brine, and concentrated under reduced pressure. The crude product was purified on a silica gel column (chloroform / methanol) to give Intermediate 12.
中間体13、14の合成 Synthesis of intermediates 13 and 14
ナスフラスコに中間体12とクロロホルムを加え、溶解した。TFA(トリフルオロ酢酸)を加え、40℃で1時間撹拌した。減圧濃縮し中間体13を得た。ナスフラスコに中間体13とDMF,ジイソプロピルエチルアミンを加え、撹拌した。塩化カルシウム管を接続し、中間体3のDMF溶液を添加し、室温で終夜撹拌した。減圧濃縮後、クロロホルム/水で分液し、有機相を飽和食塩水で洗浄し、減圧濃縮した。シリカゲルカラム(クロロホルム/メタノール)で精製し、中間体14を得た。 Intermediate 12 and chloroform were added to the eggplant flask and dissolved. TFA (trifluoroacetic acid) was added, and the mixture was stirred at 40 ° C. for 1 hour. It was concentrated under reduced pressure to obtain Intermediate 13. Intermediate 13, DMF, and diisopropylethylamine were added to the eggplant flask, and the mixture was stirred. A calcium chloride tube was connected, a DMF solution of Intermediate 3 was added, and the mixture was stirred overnight at room temperature. After concentration under reduced pressure, the mixture was separated with chloroform / water, the organic phase was washed with saturated brine, and concentrated under reduced pressure. Purification with a silica gel column (chloroform / methanol) gave Intermediate 14.
脂質二分子膜染色用色素15の合成
Synthesis of
ナスフラスコに中間体14とクロロホルムを加え、溶解した。TFA(トリフルオロ酢酸)を加え、40℃で1時間撹拌した。減圧濃縮した。粗生成物を逆相HPLC(0.1%TFAを含む水/アセトニトリル)で精製し、緑色発光する脂質二分子膜染色用色素15を得た。
Intermediate 14 and chloroform were added to the eggplant flask and dissolved. TFA (trifluoroacetic acid) was added, and the mixture was stirred at 40 ° C. for 1 hour. Concentrated under reduced pressure. The crude product was purified by reverse phase HPLC (water / acetonitrile containing 0.1% TFA) to obtain a
中間体16の合成 Synthesis of intermediate 16
ナスフラスコに中間体4とピリジンを加え、還流管を接続し撹拌した。マロンアルデヒドジアニリド塩酸塩を加え、終夜加熱還流した。減圧濃縮し、クロロホルム/1M塩酸で分液し、有機相を飽和食塩水で洗浄し減圧濃縮した。粗生成物をシリカゲルカラム(クロロホルム/メタノール)で精製し、中間体16を得た。 Intermediate 4 and pyridine were added to the eggplant flask, a reflux tube was connected, and the mixture was stirred. Malonaldehyde dianilide hydrochloride was added, and the mixture was heated under reflux overnight. The mixture was concentrated under reduced pressure, separated with chloroform / 1M hydrochloric acid, and the organic phase was washed with saturated brine and concentrated under reduced pressure. The crude product was purified on a silica gel column (chloroform / methanol) to give Intermediate 16.
中間体17の合成 Synthesis of intermediate 17
ナスフラスコに中間体16とDMF,HATUを加え、塩化カルシウム管を接続し撹拌した。中間体1、ジイソプロピルエチルアミンを含むDMF溶液を添加し、終夜撹拌した。減圧濃縮し、クロロホルム/5%クエン酸水溶液で分液し、有機相を飽和食塩水で洗浄し、減圧濃縮した。粗生成物をシリカゲルカラム(クロロホルム/メタノール)で精製し、中間体17を得た。 Intermediate 16 and DMF and HATU were added to the eggplant flask, a calcium chloride tube was connected, and the mixture was stirred. A DMF solution containing Intermediate 1 and diisopropylethylamine was added and stirred overnight. The mixture was concentrated under reduced pressure, separated by a chloroform / 5% aqueous citric acid solution, the organic phase was washed with saturated brine, and concentrated under reduced pressure. The crude product was purified by silica gel column (chloroform / methanol) to obtain Intermediate 17.
中間体18、19の合成 Synthesis of intermediates 18 and 19
ナスフラスコに中間体17とクロロホルムを加え、溶解した。TFA(トリフルオロ酢酸)を加え、40℃で1時間撹拌した。減圧濃縮し中間体18を得た。ナスフラスコに中間体18とDMF,ジイソプロピルエチルアミンを加え、撹拌した。塩化カルシウム管を接続し、中間体3のDMF溶液を添加し、室温で終夜撹拌した。減圧濃縮後、クロロホルム/水で分液し、有機相を飽和食塩水で洗浄し、減圧濃縮した。シリカゲルカラム(クロロホルム/メタノール)で精製し、中間体19を得た。 Intermediate 17 and chloroform were added to the eggplant flask and dissolved. TFA (trifluoroacetic acid) was added, and the mixture was stirred at 40 ° C. for 1 hour. It was concentrated under reduced pressure to obtain Intermediate 18. Intermediate 18, DMF, and diisopropylethylamine were added to the eggplant flask, and the mixture was stirred. A calcium chloride tube was connected, a DMF solution of Intermediate 3 was added, and the mixture was stirred overnight at room temperature. After concentration under reduced pressure, the mixture was separated with chloroform / water, the organic phase was washed with saturated brine, and concentrated under reduced pressure. Purification was performed on a silica gel column (chloroform / methanol) to obtain Intermediate 19.
脂質二分子膜染色用色素20の合成
Synthesis of
ナスフラスコに中間体19とクロロホルムを加え、溶解した。TFA(トリフルオロ酢酸)を加え、40℃で1時間撹拌した。減圧濃縮した。粗生成物を逆相HPLC(0.1%TFAを含む水/アセトニトリル)で精製し、紫色に発光する脂質二分子膜染色用色素20を得た。
Intermediate 19 and chloroform were added to the eggplant flask and dissolved. TFA (trifluoroacetic acid) was added, and the mixture was stirred at 40 ° C. for 1 hour. Concentrated under reduced pressure. The crude product was purified by reverse phase HPLC (water / acetonitrile containing 0.1% TFA) to obtain a
実施例2:エキソソーム染色試験
通常の細胞より10倍程度エキソソーム分泌量の多いHEK293Sを培養し、超遠心分離によりエキソソームを分離した。100μLのリン酸緩衝生理食塩水(PBS)にエキソソームを分散し、タンパク質含量5μg及び10μgのエキソソーム含有試料溶液を調製した。これに脂質二分子膜染色用色素9、15、20を、終濃度が10μmol/Lとなるように添加し、37℃で30分間インキュベートした。限外ろ過膜で溶液中に残存した脂質二分子膜染色用色素を除去後、ろ過膜上のエキソソームを回収し、蛍光顕微鏡観察を行った。
Example 2: Exosome staining test HEK293S, which secretes about 10 times more exosomes than normal cells, was cultured, and exosomes were separated by ultracentrifugation. Exosomes were dispersed in 100 μL of phosphate buffered saline (PBS) to prepare exosome-containing sample solutions having a protein content of 5 μg and 10 μg. To this,
結果を図1に示す。いずれの脂質二分子膜染色用色素においても、エキソソームの量に比例して染色像が観察されることが確認された。 The results are shown in FIG. It was confirmed that a stained image was observed in proportion to the amount of exosomes in any of the dyes for lipid bilayer staining.
実施例3:凝集体又は粒子形成の有無の確認
実施例2と同様の方法を用いて調製したタンパク質含量10μgのエキソソーム含有試料液に、脂質二分子膜染色用色素9、15、20を、終濃度が10μmol/Lとなるように添加し、或いは比較のために市販の脂質二分子膜染色用色素(PKH67、PKH26(シグマアルドリッチ社製))を、終濃度が10μmol/Lとなるように添加し、37℃で24時間インキュベートした。限外ろ過膜で溶液中に残存した脂質二分子膜染色用色素を除去後、ろ過膜上のエキソソームを回収し、蛍光顕微鏡観察を行った。併せて、エキソソーム非存在下で同様の操作を行った。
Example 3: Confirmation of presence / absence of aggregate or
結果を図2及び図3に示す。図2に示すように、脂質二分子膜染色用色素9、15、20では、エキソソーム存在下(Exo+)では染色像が観察され、エキソソーム非存在下(Exo−)では観察されなかった。一方、図3に示すように、エキソソーム存在下(Exo+)でPKH67及びPKH26を用いて染色を行った場合、エキソソームのサイズよりも大きく不規則な輝点が観察された。これらの結果は、PKH67及びPKH26においては、エキソソームの染色像以外に色素の凝集体又は粒子が形成され、それに由来する輝点が観察されているのに対し、脂質二分子膜染色用色素9、15、20では、凝集体又は粒子に由来する輝点が観察されなかった。
The results are shown in FIGS. 2 and 3. As shown in FIG. 2, in the
図4及び図5に、ナノ粒子トラッキング解析(NTA)により、各試料の粒子数及び粒子径を測定した結果を示す。図4及び図5において、「Exo」は染色を行っていないエキソソーム含有試料溶液の測定結果を示す。図4より、PKH67及びPKH26を用いて染色を行った場合には、粒子数の減少及び粒子径の増大が観測された。この結果は、PKH67及びPKH26がエキソソームの性質を変化させることを示している。 4 and 5 show the results of measuring the number of particles and the particle size of each sample by nanoparticle tracking analysis (NTA). In FIGS. 4 and 5, "Exo" indicates the measurement result of the unstained exosome-containing sample solution. From FIG. 4, when staining was performed using PKH67 and PKH26, a decrease in the number of particles and an increase in the particle size were observed. This result indicates that PKH67 and PKH26 alter the properties of exosomes.
一方、図5の結果より、脂質二分子膜染色用色素9、15、20は、粒子数及び粒子径を変化させないことを示しており、これらの脂質二分子膜染色用色素は、いずれもエキソソームの性質を変化させないことを示している。
On the other hand, the results of FIG. 5 show that the
実施例5:HeLa細胞染色試験
HeLa細胞をマイクロウェルスライドに播種(0.75×104cells/ウェル)した。培地として、MEM培地(10%FBS(ウシ胎児血清)含有)を用い、37℃、CO2インキュベータ内で終夜培養後、MEM培地(FBS含有又は不含有)で細胞を洗浄した。市販の脂質二分子膜染色用色素であるDil(サーモフィッシャーサイエンティフィック社製:長鎖アルキル基を有するカルボシアニン系色素)、PKH26又は脂質二分子膜染色用色素9のMEM(0又は10%FBS)溶液(1μmol/L)を調製し、細胞に添加した。室温で5分静置後、対応するFBS含量のMEM培地で洗浄した。蛍光顕微鏡(倍率×63)で観察した。
Example 5: HeLa cell staining test HeLa cells were seeded on microwell slides (0.75 × 10 4 cells / well). As a medium, MEM medium (containing 10% FBS (fetal bovine serum)) was used, and after culturing overnight in a CO 2 incubator at 37 ° C., cells were washed with MEM medium (containing or not containing FBS). MEM (0 or 10%) of commercially available dye for lipid bilayer dyeing, Dil (manufactured by Thermo Fisher Scientific Co., Ltd .: carbocyanine dye having a long-chain alkyl group), PKH26 or dye for
結果を図6(洗浄及び染色液としてFBS不含有MEM培地を用いた場合)及び図7(洗浄及び染色液としてFBS含有MEM培地を用いた場合)に示す。図6及び図7において、「FLU」は蛍光染色像、「merged with DIC」は蛍光染色像を微分干渉像と重ね合わせた画像を示す。図6のFBS非存在下では脂質二分子膜染色用色素9およびPKH26は細胞膜を選択的に明瞭に染色することが確認された。PKH26の場合、若干の細胞質内への移行と輝点が認められた。一方、Dilを用いた場合、細胞の染色は観察されず、凝集体又は粒子の形成に起因すると思われる輝点の存在が併せて観察された。図7のFBS存在下では脂質二分子膜染色用色素9のみで細胞膜が明瞭に染色された染色像が観察された。DilはFBS非存在下と同様に凝集体又は粒子の形成に起因すると思われる輝点が観察され、PKH26もFBS存在下では同様の輝点が観察された。Dilは水溶性が低く、水溶液中では凝集して懸濁状態になっているため、細胞を染色することができないと考えられる。PKH26は、FBS非存在下では細胞膜の染色が可能だが、FBS中の脂溶性成分に色素が吸着するため、FBS存在下では細胞膜の染色像が観察されなかったと考えられる。それに対し、脂質二分子膜染色用色素9は水溶性が高く、細胞膜への滞留性及び局在性が高いため、FBSの有無にかかわらず細胞膜を選択的に染色していることが確認された。
The results are shown in FIG. 6 (when FBS-free MEM medium is used as the washing and staining solution) and FIG. 7 (when FBS-containing MEM medium is used as the washing and staining solution). In FIGS. 6 and 7, “FLU” indicates a fluorescence-stained image, and “merged with DIC” indicates an image in which the fluorescence-stained image is superimposed on the differential interference contrast image. In the absence of FBS in FIG. 6, it was confirmed that the
Claims (12)
Xは、酸素、イオウ、セレン又は式−CR11 2−(R11は、水素原子又は炭素数1〜5のアルキル基である。)で表される原子又は原子団であり、
nは、1又は2の自然数であり、
R1は、炭素数1〜12のアルキレン基であり、
R2は、式(CH2CH2O)m(mは、1〜10の自然数である。)で表されるポリオキシエチレン基を含む原子団であり、
R3は、炭素数6〜20のアルキル基であり、
L1、L2及びL3は、それぞれ独立して、エステル結合(−CO−O−)、アミド結合(−CO−NH−)、ウレタン結合(−NH−CO−O−)及び尿素結合(−NH−CO−NH−)からなる群より選択される結合基であり、
qは1〜5の自然数である。 A dye for dyeing a lipid bilayer membrane represented by the following general formula (I).
X is oxygen, sulfur, selenium or formula -CR 11 2 - (. R 11 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms) is an atom or an atomic group represented by,
n is a natural number of 1 or 2
R 1 is an alkylene group having 1 to 12 carbon atoms.
R 2 is an atomic group containing a polyoxyethylene group represented by the formula (CH 2 CH 2 O) m (m is a natural number of 1 to 10).
R 3 is an alkyl group having 6 to 20 carbon atoms.
L 1 , L 2 and L 3 independently have an ester bond (-CO-O-), an amide bond (-CO-NH-), a urethane bond (-NH-CO-O-) and a urea bond (-NH-CO-O-). -NH-CO-NH-) is a binding group selected from the group consisting of
q is a natural number from 1 to 5.
下記の一般式(I)で表される脂質二分子膜染色用色素及び/又はそれを含む染色用組成物を準備する工程と、
前記脂質二分子膜染色用色素又は前記染色用組成物を前記試料溶液に添加し、前記脂質二分子膜を染色する工程を含む脂質二分子膜の染色方法。
Xは、酸素、イオウ、セレン又は式−CR11 2−(R11は、水素原子又は炭素数1〜5のアルキル基である。)で表される原子又は原子団であり、
nは、1又は2の自然数であり、
R1は、炭素数1〜12のアルキレン基であり、
R2は、式(CH2CH2O)m(mは、1〜10の自然数である。)で表されるポリオキシエチレン基を含む原子団であり、
R3は、炭素数6〜20のアルキル基であり、
L1、L2及びL3は、それぞれ独立して、エステル結合(−CO−O−)、アミド結合(−CO−NH−)、ウレタン結合(−NH−CO−O−)及び尿素結合(−NH−CO−NH−)からなる群より選択される結合基であり、
qは1〜5の自然数である。 The process of preparing a sample solution containing a lipid bilayer membrane and
A step of preparing a dye for lipid bilayer film dyeing represented by the following general formula (I) and / or a dyeing composition containing the same, and
A method for dyeing a lipid bilayer membrane, which comprises a step of adding the dye for dyeing the lipid bilayer membrane or the dyeing composition to the sample solution and dyeing the lipid bilayer membrane.
X is oxygen, sulfur, selenium or formula -CR 11 2 - (. R 11 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms) is an atom or an atomic group represented by,
n is a natural number of 1 or 2
R 1 is an alkylene group having 1 to 12 carbon atoms.
R 2 is an atomic group containing a polyoxyethylene group represented by the formula (CH 2 CH 2 O) m (m is a natural number of 1 to 10).
R 3 is an alkyl group having 6 to 20 carbon atoms.
L 1 , L 2 and L 3 independently have an ester bond (-CO-O-), an amide bond (-CO-NH-), a urethane bond (-NH-CO-O-) and a urea bond (-NH-CO-O-). -NH-CO-NH-) is a binding group selected from the group consisting of
q is a natural number from 1 to 5.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019211329A JP7423888B2 (en) | 2019-11-22 | 2019-11-22 | Dye for staining lipid bilayer membranes and method for staining lipid bilayer membranes using the same |
PCT/JP2020/043462 WO2021100864A1 (en) | 2019-11-22 | 2020-11-20 | Dye for staining lipid bilayer film and method for staining lipid bilayer film using same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019211329A JP7423888B2 (en) | 2019-11-22 | 2019-11-22 | Dye for staining lipid bilayer membranes and method for staining lipid bilayer membranes using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021080416A true JP2021080416A (en) | 2021-05-27 |
JP7423888B2 JP7423888B2 (en) | 2024-01-30 |
Family
ID=75964269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019211329A Active JP7423888B2 (en) | 2019-11-22 | 2019-11-22 | Dye for staining lipid bilayer membranes and method for staining lipid bilayer membranes using the same |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP7423888B2 (en) |
WO (1) | WO2021100864A1 (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08502719A (en) * | 1991-11-27 | 1996-03-26 | ザイナクシス、インコーポレーテッド | Compounds, compositions, and methods for binding bioactive agents to bioparticle surface membranes |
JP2003501540A (en) * | 1999-06-09 | 2003-01-14 | カーネギー メロン ユニヴァーシティ | PH-functional cyanine dyes as reactive fluorescent reagents |
CN103030989A (en) * | 2012-12-10 | 2013-04-10 | 北京化工大学 | Synthesis method of water-soluble squarylium indocyanine multifunctional cell fluorescent dye |
US20130230466A1 (en) * | 2012-03-02 | 2013-09-05 | Greg Hermanson | Cyanine compounds |
US20150330973A1 (en) * | 2004-10-25 | 2015-11-19 | Anaspec Incorporated | Kits for analysis of biological samples |
JP2016161480A (en) * | 2015-03-04 | 2016-09-05 | 国立大学法人 千葉大学 | Quantitative determination and diagnosis of microvesicle of minute amount and screening method |
CN106053405A (en) * | 2016-05-10 | 2016-10-26 | 东南大学 | A super-resolution optical imaging method based on a single-molecule positioning process |
US20170197916A1 (en) * | 2016-01-08 | 2017-07-13 | BroadPharm | Functionalized pegylated cyanine compounds, pharmaceutical compositions, and methods of use thereof |
-
2019
- 2019-11-22 JP JP2019211329A patent/JP7423888B2/en active Active
-
2020
- 2020-11-20 WO PCT/JP2020/043462 patent/WO2021100864A1/en active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08502719A (en) * | 1991-11-27 | 1996-03-26 | ザイナクシス、インコーポレーテッド | Compounds, compositions, and methods for binding bioactive agents to bioparticle surface membranes |
JP2003501540A (en) * | 1999-06-09 | 2003-01-14 | カーネギー メロン ユニヴァーシティ | PH-functional cyanine dyes as reactive fluorescent reagents |
US20150330973A1 (en) * | 2004-10-25 | 2015-11-19 | Anaspec Incorporated | Kits for analysis of biological samples |
US20130230466A1 (en) * | 2012-03-02 | 2013-09-05 | Greg Hermanson | Cyanine compounds |
CN103030989A (en) * | 2012-12-10 | 2013-04-10 | 北京化工大学 | Synthesis method of water-soluble squarylium indocyanine multifunctional cell fluorescent dye |
JP2016161480A (en) * | 2015-03-04 | 2016-09-05 | 国立大学法人 千葉大学 | Quantitative determination and diagnosis of microvesicle of minute amount and screening method |
US20170197916A1 (en) * | 2016-01-08 | 2017-07-13 | BroadPharm | Functionalized pegylated cyanine compounds, pharmaceutical compositions, and methods of use thereof |
CN106053405A (en) * | 2016-05-10 | 2016-10-26 | 东南大学 | A super-resolution optical imaging method based on a single-molecule positioning process |
Non-Patent Citations (1)
Title |
---|
SATO, SHIN-ICHI ET AL.: "Live-cell imaging endogenous mRNAs with a small molecule", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, vol. Vol.54, No.6,, JPN6021002960, 2015, pages 1855 - 1858, ISSN: 0005216103 * |
Also Published As
Publication number | Publication date |
---|---|
WO2021100864A1 (en) | 2021-05-27 |
JP7423888B2 (en) | 2024-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW422841B (en) | Pharmaceutical composition for diagnosis of a disease state in an animal, pharmaceutical composition for imaging an animal, method for the in vitro immunoassay or DNA hybridization of a tissue sample and process for preparing a complex of said compounds | |
JP4695811B2 (en) | Zinc fluorescent probe | |
US4496722A (en) | Reporter compounds | |
CN107849441A (en) | AIE illuminators for visualization and the treatment of cancer | |
US20080145526A1 (en) | Luminescent Metal Complexes and Associated Technology | |
CN105670609B (en) | A kind of novel Rhodamine fluorescent probe and preparation method thereof of detection mercury ion | |
JP5592879B2 (en) | Selective extraction method of membrane protein using calixarene | |
KR20150133792A (en) | Fluorescent-hap: a diagnostic stain for hbv cores in cells | |
WO2010028349A2 (en) | Fluorochromes for organelle tracing and multi-color imaging | |
WO2014136780A1 (en) | Fluorescent probe for detecting activity of calpain | |
US8557811B2 (en) | Dual-color imaging method of sodium/calcium activities using two-photon fluorescent probes and preparation method of two-photon fluorescent probes | |
WO2021100864A1 (en) | Dye for staining lipid bilayer film and method for staining lipid bilayer film using same | |
Wang et al. | A reduction-responsive liposomal nanocarrier with self-reporting ability for efficient gene delivery | |
US7696245B2 (en) | Fluorescent probe for zinc | |
Bertazza et al. | Cell penetrating silica nanoparticles doped with two-photon absorbing fluorophores | |
CA3050677C (en) | Novel norbornene-based amphiphilic compound and use thereof | |
WO2017146145A1 (en) | Ph responsive fluorescent compound, composition for detecting mitophagy using same, and method for detecting mitophagy within cells | |
KR102122806B1 (en) | Two-photon probes for Golgi apparatus | |
CN103435625A (en) | Red light emission rhodamine-based ionic fluorescent probe and application thereof | |
US20200131160A1 (en) | Zinc indicators for cellular imaging | |
US11591476B2 (en) | In-vivo probe for real time longitudinal monitoring of inducible nitric-oxide synthase in living cells and animals | |
CN104031636B (en) | Nanometer ball of a kind of autofluorescence and preparation method thereof and application | |
JP5229700B2 (en) | Novel fluorescent compound and method for detecting intracellular cholesterol using the same | |
JP2001522348A (en) | Diagnostic imaging agents with improved serum relaxivity (In-Serum-Relaxity) | |
EP0110879A1 (en) | Reporter compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221025 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20231212 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20231226 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7423888 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |